This study uses National Health and Nutrition Examination Survey data through 2013-2014 to update previously reported trends in the prevalence of obesity and extreme obesity in children and adolescents aged 2 to 19 years.
Ikramuddin and coauthors found that the use of vagal verve block therapy to treat morbidly obese patients proved more effective than a sham device but did not reach statistical superiority and was associated with more adverse effects than the sham device.
Puzziferri and coauthors assessed the quality of evidence and treatment effectiveness after bariatric procedures for weight loss, type 2 diabetes, hypertension, and hyperlipidemia in severely obese adults by reviewing clinical studies that had more than 2 years of outcome information and follow-up measures for at least 80% of the initial cohort.
Kushner and Ryan review current best practices for assessment and lifestyle management of obesity and describe how updated guidelines can be applied to individual patients.
Ogden and coauthors provide the most recent national estimates of childhood obesity, including prevalence and trends, as well as detailed obesity trend analyses among adults.
This population-based observational study reports that use of 2 Joint Commission obstetric quality indicators are not associated with maternal and neonatal morbidity.
Because 36% of US adults are obese with many unable to lose weight to improve health, Yanovski and Yanovski systematically review medications currently approved for obesity treatment and discuss off-label use of medications studied for obesity and use of obesity medications in clinical practice.
This randomized clinical trial determines whether diet or exercise improves exercise capacity and quality of life among obese older patients with heart failure with preserved ejection fraction (HFPEF).